nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—breast cancer	0.216	0.538	CbGaD
Dihydrocodeine—CYP3A4—breast cancer	0.185	0.462	CbGaD
Dihydrocodeine—CYP3A4—Exemestane—breast cancer	0.0429	0.103	CbGbCtD
Dihydrocodeine—CYP2D6—Idarubicin—breast cancer	0.0387	0.093	CbGbCtD
Dihydrocodeine—CYP3A4—Letrozole—breast cancer	0.0365	0.0876	CbGbCtD
Dihydrocodeine—CYP3A4—Anastrozole—breast cancer	0.0325	0.0781	CbGbCtD
Dihydrocodeine—CYP3A4—Toremifene—breast cancer	0.0297	0.0714	CbGbCtD
Dihydrocodeine—CYP3A4—Fulvestrant—breast cancer	0.0276	0.0664	CbGbCtD
Dihydrocodeine—CYP3A4—Thiotepa—breast cancer	0.0246	0.0592	CbGbCtD
Dihydrocodeine—CYP3A4—Ixabepilone—breast cancer	0.0225	0.0541	CbGbCtD
Dihydrocodeine—CYP3A4—Lapatinib—breast cancer	0.0217	0.0521	CbGbCtD
Dihydrocodeine—CYP2D6—Vinorelbine—breast cancer	0.0189	0.0454	CbGbCtD
Dihydrocodeine—CYP2D6—Tamoxifen—breast cancer	0.0171	0.041	CbGbCtD
Dihydrocodeine—CYP3A4—Raloxifene—breast cancer	0.0164	0.0395	CbGbCtD
Dihydrocodeine—CYP3A4—Vinorelbine—breast cancer	0.012	0.0289	CbGbCtD
Dihydrocodeine—CYP2D6—Vinblastine—breast cancer	0.0117	0.028	CbGbCtD
Dihydrocodeine—CYP3A4—Tamoxifen—breast cancer	0.0109	0.0261	CbGbCtD
Dihydrocodeine—CYP3A4—Mitoxantrone—breast cancer	0.0106	0.0254	CbGbCtD
Dihydrocodeine—CYP3A4—Paclitaxel—breast cancer	0.00845	0.0203	CbGbCtD
Dihydrocodeine—CYP3A4—Irinotecan—breast cancer	0.00834	0.02	CbGbCtD
Dihydrocodeine—CYP3A4—Vinblastine—breast cancer	0.00741	0.0178	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—breast cancer	0.00716	0.0172	CbGbCtD
Dihydrocodeine—CYP3A4—Docetaxel—breast cancer	0.00611	0.0147	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—breast cancer	0.00455	0.0109	CbGbCtD
Dihydrocodeine—Galantamine—ACHE—breast cancer	0.000444	0.118	CrCbGaD
Dihydrocodeine—Galantamine—BCHE—breast cancer	0.000261	0.0693	CrCbGaD
Dihydrocodeine—Hydromorphone—PTGS1—breast cancer	0.000221	0.0586	CrCbGaD
Dihydrocodeine—Oxymorphone—CYP2D6—breast cancer	0.000207	0.0551	CrCbGaD
Dihydrocodeine—Ethylmorphine—CYP2D6—breast cancer	0.000198	0.0526	CrCbGaD
Dihydrocodeine—Hydrocodone—CYP2D6—breast cancer	0.000181	0.0481	CrCbGaD
Dihydrocodeine—Oxymorphone—CYP3A4—breast cancer	0.000178	0.0472	CrCbGaD
Dihydrocodeine—Ethylmorphine—CYP3A4—breast cancer	0.00017	0.0451	CrCbGaD
Dihydrocodeine—Oxycodone—CYP2D6—breast cancer	0.000165	0.0439	CrCbGaD
Dihydrocodeine—Codeine—CYP2D6—breast cancer	0.000158	0.0419	CrCbGaD
Dihydrocodeine—Hydrocodone—CYP3A4—breast cancer	0.000155	0.0413	CrCbGaD
Dihydrocodeine—Dermatitis—Melphalan—breast cancer	0.000152	0.00103	CcSEcCtD
Dihydrocodeine—Dyspnoea—Gemcitabine—breast cancer	0.00015	0.00102	CcSEcCtD
Dihydrocodeine—Nausea—Vinblastine—breast cancer	0.00015	0.00102	CcSEcCtD
Dihydrocodeine—Hydromorphone—CYP2D6—breast cancer	0.00015	0.0399	CrCbGaD
Dihydrocodeine—Somnolence—Gemcitabine—breast cancer	0.00015	0.00102	CcSEcCtD
Dihydrocodeine—Convulsion—Paclitaxel—breast cancer	0.00015	0.00102	CcSEcCtD
Dihydrocodeine—Affect lability—Doxorubicin—breast cancer	0.00015	0.00101	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Irinotecan—breast cancer	0.00015	0.00101	CcSEcCtD
Dihydrocodeine—Vomiting—Goserelin—breast cancer	0.000149	0.00101	CcSEcCtD
Dihydrocodeine—Paraesthesia—Fluorouracil—breast cancer	0.000149	0.00101	CcSEcCtD
Dihydrocodeine—Pruritus—Vinorelbine—breast cancer	0.000149	0.00101	CcSEcCtD
Dihydrocodeine—Constipation—Irinotecan—breast cancer	0.000148	0.001	CcSEcCtD
Dihydrocodeine—Constipation—Mitoxantrone—breast cancer	0.000148	0.001	CcSEcCtD
Dihydrocodeine—Angiopathy—Capecitabine—breast cancer	0.000148	0.001	CcSEcCtD
Dihydrocodeine—Dyspnoea—Fluorouracil—breast cancer	0.000148	0.001	CcSEcCtD
Dihydrocodeine—Rash—Goserelin—breast cancer	0.000148	0.001	CcSEcCtD
Dihydrocodeine—Dermatitis—Goserelin—breast cancer	0.000148	0.001	CcSEcCtD
Dihydrocodeine—Mental disorder—Docetaxel—breast cancer	0.000148	0.000999	CcSEcCtD
Dihydrocodeine—Somnolence—Fluorouracil—breast cancer	0.000148	0.000998	CcSEcCtD
Dihydrocodeine—Immune system disorder—Capecitabine—breast cancer	0.000147	0.000998	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Capecitabine—breast cancer	0.000147	0.000995	CcSEcCtD
Dihydrocodeine—Headache—Goserelin—breast cancer	0.000147	0.000994	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000146	0.000991	CcSEcCtD
Dihydrocodeine—Nausea—Tamoxifen—breast cancer	0.000146	0.000987	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000146	0.000986	CcSEcCtD
Dihydrocodeine—Constipation—Gemcitabine—breast cancer	0.000144	0.000977	CcSEcCtD
Dihydrocodeine—Dry mouth—Paclitaxel—breast cancer	0.000144	0.000976	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—breast cancer	0.000144	0.000975	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vinorelbine—breast cancer	0.000144	0.000973	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000143	0.000969	CcSEcCtD
Dihydrocodeine—Galantamine—CYP2D6—breast cancer	0.000143	0.038	CrCbGaD
Dihydrocodeine—Mental disorder—Capecitabine—breast cancer	0.000143	0.000968	CcSEcCtD
Dihydrocodeine—Nausea—Melphalan—breast cancer	0.000143	0.000967	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Mitoxantrone—breast cancer	0.000143	0.000966	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Irinotecan—breast cancer	0.000143	0.000966	CcSEcCtD
Dihydrocodeine—Confusional state—Paclitaxel—breast cancer	0.000143	0.000964	CcSEcCtD
Dihydrocodeine—Pruritus—Thiotepa—breast cancer	0.000142	0.000961	CcSEcCtD
Dihydrocodeine—Oxycodone—CYP3A4—breast cancer	0.000142	0.0377	CrCbGaD
Dihydrocodeine—Gastrointestinal pain—Irinotecan—breast cancer	0.000142	0.000959	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000142	0.000959	CcSEcCtD
Dihydrocodeine—Nausea—Goserelin—breast cancer	0.000139	0.000943	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Gemcitabine—breast cancer	0.000139	0.000941	CcSEcCtD
Dihydrocodeine—Dizziness—Vinorelbine—breast cancer	0.000139	0.00094	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Paclitaxel—breast cancer	0.000139	0.000938	CcSEcCtD
Dihydrocodeine—Urticaria—Mitoxantrone—breast cancer	0.000138	0.000931	CcSEcCtD
Dihydrocodeine—Diarrhoea—Thiotepa—breast cancer	0.000137	0.000929	CcSEcCtD
Dihydrocodeine—Skin disorder—Paclitaxel—breast cancer	0.000137	0.000929	CcSEcCtD
Dihydrocodeine—Abdominal pain—Irinotecan—breast cancer	0.000137	0.000927	CcSEcCtD
Dihydrocodeine—Abdominal pain—Mitoxantrone—breast cancer	0.000137	0.000927	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Fluorouracil—breast cancer	0.000137	0.000925	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Paclitaxel—breast cancer	0.000137	0.000924	CcSEcCtD
Dihydrocodeine—Codeine—CYP3A4—breast cancer	0.000135	0.0359	CrCbGaD
Dihydrocodeine—Vomiting—Vinorelbine—breast cancer	0.000134	0.000904	CcSEcCtD
Dihydrocodeine—Dizziness—Thiotepa—breast cancer	0.000133	0.000898	CcSEcCtD
Dihydrocodeine—Rash—Vinorelbine—breast cancer	0.000132	0.000896	CcSEcCtD
Dihydrocodeine—Dermatitis—Vinorelbine—breast cancer	0.000132	0.000896	CcSEcCtD
Dihydrocodeine—Hypotension—Paclitaxel—breast cancer	0.000132	0.000894	CcSEcCtD
Dihydrocodeine—Urticaria—Fluorouracil—breast cancer	0.000132	0.000892	CcSEcCtD
Dihydrocodeine—Headache—Vinorelbine—breast cancer	0.000132	0.000891	CcSEcCtD
Dihydrocodeine—Hydromorphone—CYP3A4—breast cancer	0.000129	0.0342	CrCbGaD
Dihydrocodeine—Hepatobiliary disease—Methotrexate—breast cancer	0.000128	0.000866	CcSEcCtD
Dihydrocodeine—Vertigo—Capecitabine—breast cancer	0.000128	0.000864	CcSEcCtD
Dihydrocodeine—Morphine—CYP2D6—breast cancer	0.000128	0.0339	CrCbGaD
Dihydrocodeine—Vomiting—Thiotepa—breast cancer	0.000128	0.000863	CcSEcCtD
Dihydrocodeine—Convulsion—Docetaxel—breast cancer	0.000127	0.00086	CcSEcCtD
Dihydrocodeine—Paraesthesia—Paclitaxel—breast cancer	0.000127	0.000859	CcSEcCtD
Dihydrocodeine—Rash—Thiotepa—breast cancer	0.000127	0.000856	CcSEcCtD
Dihydrocodeine—Dermatitis—Thiotepa—breast cancer	0.000126	0.000855	CcSEcCtD
Dihydrocodeine—Dyspnoea—Paclitaxel—breast cancer	0.000126	0.000852	CcSEcCtD
Dihydrocodeine—Headache—Thiotepa—breast cancer	0.000126	0.000851	CcSEcCtD
Dihydrocodeine—Somnolence—Paclitaxel—breast cancer	0.000126	0.00085	CcSEcCtD
Dihydrocodeine—Nausea—Vinorelbine—breast cancer	0.000125	0.000844	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000124	0.00084	CcSEcCtD
Dihydrocodeine—Galantamine—CYP3A4—breast cancer	0.000123	0.0326	CrCbGaD
Dihydrocodeine—Dry mouth—Docetaxel—breast cancer	0.000122	0.000827	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000122	0.000826	CcSEcCtD
Dihydrocodeine—Constipation—Paclitaxel—breast cancer	0.000121	0.000818	CcSEcCtD
Dihydrocodeine—Confusional state—Docetaxel—breast cancer	0.000121	0.000817	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.00012	0.000813	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—breast cancer	0.00012	0.000812	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—breast cancer	0.00012	0.000811	CcSEcCtD
Dihydrocodeine—Pruritus—Gemcitabine—breast cancer	0.000119	0.000808	CcSEcCtD
Dihydrocodeine—Nausea—Thiotepa—breast cancer	0.000119	0.000806	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—breast cancer	0.000119	0.000806	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mitoxantrone—breast cancer	0.000119	0.000802	CcSEcCtD
Dihydrocodeine—Diarrhoea—Irinotecan—breast cancer	0.000119	0.000802	CcSEcCtD
Dihydrocodeine—Dry mouth—Capecitabine—breast cancer	0.000118	0.000801	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Docetaxel—breast cancer	0.000117	0.000795	CcSEcCtD
Dihydrocodeine—Pruritus—Fluorouracil—breast cancer	0.000117	0.000794	CcSEcCtD
Dihydrocodeine—Confusional state—Capecitabine—breast cancer	0.000117	0.000791	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Paclitaxel—breast cancer	0.000116	0.000788	CcSEcCtD
Dihydrocodeine—Skin disorder—Docetaxel—breast cancer	0.000116	0.000787	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000116	0.000782	CcSEcCtD
Dihydrocodeine—Diarrhoea—Gemcitabine—breast cancer	0.000116	0.000781	CcSEcCtD
Dihydrocodeine—Dizziness—Irinotecan—breast cancer	0.000115	0.000775	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Capecitabine—breast cancer	0.000114	0.00077	CcSEcCtD
Dihydrocodeine—Diarrhoea—Fluorouracil—breast cancer	0.000114	0.000768	CcSEcCtD
Dihydrocodeine—Skin disorder—Capecitabine—breast cancer	0.000113	0.000762	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Epirubicin—breast cancer	0.000112	0.00076	CcSEcCtD
Dihydrocodeine—Urticaria—Paclitaxel—breast cancer	0.000112	0.00076	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Capecitabine—breast cancer	0.000112	0.000759	CcSEcCtD
Dihydrocodeine—Hypotension—Docetaxel—breast cancer	0.000112	0.000757	CcSEcCtD
Dihydrocodeine—Abdominal pain—Paclitaxel—breast cancer	0.000112	0.000756	CcSEcCtD
Dihydrocodeine—Urethral disorder—Epirubicin—breast cancer	0.000111	0.000754	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—breast cancer	0.000111	0.00075	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—breast cancer	0.00011	0.000746	CcSEcCtD
Dihydrocodeine—Vomiting—Irinotecan—breast cancer	0.00011	0.000745	CcSEcCtD
Dihydrocodeine—Vomiting—Mitoxantrone—breast cancer	0.00011	0.000745	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—breast cancer	0.00011	0.000743	CcSEcCtD
Dihydrocodeine—Dizziness—Fluorouracil—breast cancer	0.00011	0.000743	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—breast cancer	0.00011	0.000741	CcSEcCtD
Dihydrocodeine—Morphine—CYP3A4—breast cancer	0.000109	0.0291	CrCbGaD
Dihydrocodeine—Rash—Irinotecan—breast cancer	0.000109	0.000739	CcSEcCtD
Dihydrocodeine—Rash—Mitoxantrone—breast cancer	0.000109	0.000739	CcSEcCtD
Dihydrocodeine—Dermatitis—Mitoxantrone—breast cancer	0.000109	0.000739	CcSEcCtD
Dihydrocodeine—Dermatitis—Irinotecan—breast cancer	0.000109	0.000739	CcSEcCtD
Dihydrocodeine—Headache—Irinotecan—breast cancer	0.000109	0.000735	CcSEcCtD
Dihydrocodeine—Headache—Mitoxantrone—breast cancer	0.000109	0.000735	CcSEcCtD
Dihydrocodeine—Hypotension—Capecitabine—breast cancer	0.000108	0.000733	CcSEcCtD
Dihydrocodeine—Paraesthesia—Docetaxel—breast cancer	0.000108	0.000728	CcSEcCtD
Dihydrocodeine—Vomiting—Gemcitabine—breast cancer	0.000107	0.000726	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP2D6—breast cancer	0.000107	0.0285	CrCbGaD
Dihydrocodeine—Dyspnoea—Docetaxel—breast cancer	0.000107	0.000723	CcSEcCtD
Dihydrocodeine—Somnolence—Docetaxel—breast cancer	0.000106	0.000721	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—breast cancer	0.000106	0.00072	CcSEcCtD
Dihydrocodeine—Rash—Gemcitabine—breast cancer	0.000106	0.00072	CcSEcCtD
Dihydrocodeine—Dermatitis—Gemcitabine—breast cancer	0.000106	0.000719	CcSEcCtD
Dihydrocodeine—Headache—Gemcitabine—breast cancer	0.000106	0.000715	CcSEcCtD
Dihydrocodeine—Vomiting—Fluorouracil—breast cancer	0.000106	0.000714	CcSEcCtD
Dihydrocodeine—Rash—Fluorouracil—breast cancer	0.000105	0.000708	CcSEcCtD
Dihydrocodeine—Dermatitis—Fluorouracil—breast cancer	0.000105	0.000707	CcSEcCtD
Dihydrocodeine—Paraesthesia—Capecitabine—breast cancer	0.000104	0.000705	CcSEcCtD
Dihydrocodeine—Headache—Fluorouracil—breast cancer	0.000104	0.000703	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—breast cancer	0.000104	0.000703	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000103	0.0007	CcSEcCtD
Dihydrocodeine—Dyspnoea—Capecitabine—breast cancer	0.000103	0.0007	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—breast cancer	0.000103	0.000698	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—breast cancer	0.000103	0.000698	CcSEcCtD
Dihydrocodeine—Nausea—Mitoxantrone—breast cancer	0.000103	0.000696	CcSEcCtD
Dihydrocodeine—Nausea—Irinotecan—breast cancer	0.000103	0.000696	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—breast cancer	0.000103	0.000695	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—breast cancer	0.000102	0.000693	CcSEcCtD
Dihydrocodeine—Constipation—Docetaxel—breast cancer	0.000102	0.000693	CcSEcCtD
Dihydrocodeine—Nausea—Gemcitabine—breast cancer	0.0001	0.000678	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Capecitabine—breast cancer	0.0001	0.000677	CcSEcCtD
Dihydrocodeine—Pruritus—Paclitaxel—breast cancer	0.0001	0.000677	CcSEcCtD
Dihydrocodeine—Mental disorder—Epirubicin—breast cancer	9.96e-05	0.000674	CcSEcCtD
Dihydrocodeine—Constipation—Capecitabine—breast cancer	9.92e-05	0.000671	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Docetaxel—breast cancer	9.87e-05	0.000668	CcSEcCtD
Dihydrocodeine—Nausea—Fluorouracil—breast cancer	9.86e-05	0.000667	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Docetaxel—breast cancer	9.8e-05	0.000663	CcSEcCtD
Dihydrocodeine—Diarrhoea—Paclitaxel—breast cancer	9.67e-05	0.000654	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Capecitabine—breast cancer	9.56e-05	0.000647	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—breast cancer	9.55e-05	0.000646	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—breast cancer	9.51e-05	0.000643	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—breast cancer	9.5e-05	0.000643	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Capecitabine—breast cancer	9.48e-05	0.000642	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—breast cancer	9.48e-05	0.000642	CcSEcCtD
Dihydrocodeine—Abdominal pain—Docetaxel—breast cancer	9.47e-05	0.000641	CcSEcCtD
Dihydrocodeine—Dizziness—Paclitaxel—breast cancer	9.35e-05	0.000632	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—breast cancer	9.22e-05	0.000624	CcSEcCtD
Dihydrocodeine—Urticaria—Capecitabine—breast cancer	9.21e-05	0.000623	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP3A4—breast cancer	9.19e-05	0.0244	CrCbGaD
Dihydrocodeine—Abdominal pain—Capecitabine—breast cancer	9.17e-05	0.00062	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—breast cancer	9.17e-05	0.00062	CcSEcCtD
Dihydrocodeine—Morphine—ABCB1—breast cancer	9.11e-05	0.0242	CrCbGaD
Dihydrocodeine—Vomiting—Paclitaxel—breast cancer	8.99e-05	0.000608	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.94e-05	0.000605	CcSEcCtD
Dihydrocodeine—Rash—Paclitaxel—breast cancer	8.91e-05	0.000603	CcSEcCtD
Dihydrocodeine—Dermatitis—Paclitaxel—breast cancer	8.9e-05	0.000602	CcSEcCtD
Dihydrocodeine—Vertigo—Epirubicin—breast cancer	8.9e-05	0.000602	CcSEcCtD
Dihydrocodeine—Headache—Paclitaxel—breast cancer	8.85e-05	0.000599	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—breast cancer	8.71e-05	0.000589	CcSEcCtD
Dihydrocodeine—Convulsion—Epirubicin—breast cancer	8.58e-05	0.00058	CcSEcCtD
Dihydrocodeine—Pruritus—Docetaxel—breast cancer	8.48e-05	0.000573	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—breast cancer	8.47e-05	0.000573	CcSEcCtD
Dihydrocodeine—Nausea—Paclitaxel—breast cancer	8.4e-05	0.000568	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—breast cancer	8.39e-05	0.000567	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.37e-05	0.000566	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—breast cancer	8.35e-05	0.000565	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—breast cancer	8.24e-05	0.000558	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—breast cancer	8.23e-05	0.000557	CcSEcCtD
Dihydrocodeine—Pruritus—Capecitabine—breast cancer	8.21e-05	0.000555	CcSEcCtD
Dihydrocodeine—Diarrhoea—Docetaxel—breast cancer	8.2e-05	0.000555	CcSEcCtD
Dihydrocodeine—Confusional state—Epirubicin—breast cancer	8.15e-05	0.000551	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—breast cancer	8.07e-05	0.000546	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—breast cancer	7.94e-05	0.000537	CcSEcCtD
Dihydrocodeine—Diarrhoea—Capecitabine—breast cancer	7.94e-05	0.000537	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Epirubicin—breast cancer	7.92e-05	0.000536	CcSEcCtD
Dihydrocodeine—Dizziness—Docetaxel—breast cancer	7.92e-05	0.000536	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—breast cancer	7.85e-05	0.000531	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Epirubicin—breast cancer	7.81e-05	0.000528	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—breast cancer	7.75e-05	0.000525	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.75e-05	0.000524	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—breast cancer	7.7e-05	0.000521	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—breast cancer	7.68e-05	0.000519	CcSEcCtD
Dihydrocodeine—Dizziness—Capecitabine—breast cancer	7.67e-05	0.000519	CcSEcCtD
Dihydrocodeine—Dextromethorphan—ABCB1—breast cancer	7.65e-05	0.0203	CrCbGaD
Dihydrocodeine—Dry mouth—Doxorubicin—breast cancer	7.63e-05	0.000516	CcSEcCtD
Dihydrocodeine—Vomiting—Docetaxel—breast cancer	7.62e-05	0.000515	CcSEcCtD
Dihydrocodeine—Rash—Docetaxel—breast cancer	7.55e-05	0.000511	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—breast cancer	7.55e-05	0.000511	CcSEcCtD
Dihydrocodeine—Dermatitis—Docetaxel—breast cancer	7.55e-05	0.000511	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—breast cancer	7.54e-05	0.00051	CcSEcCtD
Dihydrocodeine—Headache—Docetaxel—breast cancer	7.5e-05	0.000508	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—breast cancer	7.45e-05	0.000504	CcSEcCtD
Dihydrocodeine—Vomiting—Capecitabine—breast cancer	7.37e-05	0.000499	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—breast cancer	7.33e-05	0.000496	CcSEcCtD
Dihydrocodeine—Rash—Capecitabine—breast cancer	7.31e-05	0.000495	CcSEcCtD
Dihydrocodeine—Dermatitis—Capecitabine—breast cancer	7.31e-05	0.000494	CcSEcCtD
Dihydrocodeine—Headache—Capecitabine—breast cancer	7.27e-05	0.000492	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—breast cancer	7.26e-05	0.000491	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—breast cancer	7.26e-05	0.000491	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—breast cancer	7.23e-05	0.000489	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—breast cancer	7.2e-05	0.000487	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—breast cancer	7.18e-05	0.000486	CcSEcCtD
Dihydrocodeine—Nausea—Docetaxel—breast cancer	7.12e-05	0.000481	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—breast cancer	7.12e-05	0.000481	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—breast cancer	7.06e-05	0.000478	CcSEcCtD
Dihydrocodeine—Hypotension—Doxorubicin—breast cancer	6.99e-05	0.000473	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—breast cancer	6.98e-05	0.000472	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—breast cancer	6.91e-05	0.000467	CcSEcCtD
Dihydrocodeine—Nausea—Capecitabine—breast cancer	6.89e-05	0.000466	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—breast cancer	6.86e-05	0.000464	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—breast cancer	6.83e-05	0.000462	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—breast cancer	6.71e-05	0.000454	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—breast cancer	6.67e-05	0.000451	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—breast cancer	6.66e-05	0.00045	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—breast cancer	6.65e-05	0.00045	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—breast cancer	6.61e-05	0.000447	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—breast cancer	6.45e-05	0.000437	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—breast cancer	6.42e-05	0.000434	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—breast cancer	6.39e-05	0.000433	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—breast cancer	6.39e-05	0.000432	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—breast cancer	6.16e-05	0.000417	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—breast cancer	6.11e-05	0.000414	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—breast cancer	6.11e-05	0.000413	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—breast cancer	5.94e-05	0.000402	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—breast cancer	5.91e-05	0.0004	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—breast cancer	5.91e-05	0.0004	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—breast cancer	5.72e-05	0.000387	CcSEcCtD
Dihydrocodeine—Dizziness—Methotrexate—breast cancer	5.71e-05	0.000386	CcSEcCtD
Dihydrocodeine—Diarrhoea—Epirubicin—breast cancer	5.53e-05	0.000374	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—breast cancer	5.49e-05	0.000371	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—breast cancer	5.44e-05	0.000368	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—breast cancer	5.44e-05	0.000368	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—breast cancer	5.41e-05	0.000366	CcSEcCtD
Dihydrocodeine—Dizziness—Epirubicin—breast cancer	5.34e-05	0.000362	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—breast cancer	5.29e-05	0.000358	CcSEcCtD
Dihydrocodeine—Vomiting—Epirubicin—breast cancer	5.14e-05	0.000348	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—breast cancer	5.13e-05	0.000347	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—breast cancer	5.12e-05	0.000346	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—breast cancer	5.09e-05	0.000345	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—breast cancer	5.09e-05	0.000344	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—breast cancer	5.06e-05	0.000342	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—breast cancer	4.94e-05	0.000334	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—breast cancer	4.8e-05	0.000325	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—breast cancer	4.75e-05	0.000322	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—breast cancer	4.71e-05	0.000319	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—breast cancer	4.71e-05	0.000319	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—breast cancer	4.68e-05	0.000317	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—breast cancer	4.44e-05	0.0003	CcSEcCtD
Dihydrocodeine—CYP2D6—Metabolism—LDHB—breast cancer	1.15e-05	0.000377	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF4—breast cancer	1.15e-05	0.000376	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCR4—breast cancer	1.14e-05	0.000374	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL12—breast cancer	1.14e-05	0.000374	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PAK1—breast cancer	1.12e-05	0.000368	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—COX11—breast cancer	1.1e-05	0.000362	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TCF7L2—breast cancer	1.1e-05	0.000361	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT2—breast cancer	1.09e-05	0.000359	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCC1—breast cancer	1.09e-05	0.000357	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA3—breast cancer	1.09e-05	0.000357	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMMR—breast cancer	1.09e-05	0.000357	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CG—breast cancer	1.09e-05	0.000357	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOTCH2—breast cancer	1.06e-05	0.000348	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HSP90AA1—breast cancer	1.06e-05	0.000348	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.05e-05	0.000346	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CD—breast cancer	1.05e-05	0.000345	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRL—breast cancer	1.03e-05	0.000339	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AGTR1—breast cancer	1.03e-05	0.000339	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STK11—breast cancer	1.02e-05	0.000334	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADAM10—breast cancer	1.02e-05	0.000334	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CDA—breast cancer	1.01e-05	0.000332	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SHMT1—breast cancer	1.01e-05	0.000332	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PLG—breast cancer	1.01e-05	0.00033	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA4—breast cancer	9.95e-06	0.000327	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CA9—breast cancer	9.95e-06	0.000327	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT2—breast cancer	9.94e-06	0.000326	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF10—breast cancer	9.89e-06	0.000325	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLCO1B1—breast cancer	9.72e-06	0.000319	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC2A5—breast cancer	9.72e-06	0.000319	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GPX2—breast cancer	9.7e-06	0.000318	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA2—breast cancer	9.7e-06	0.000318	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GPX4—breast cancer	9.58e-06	0.000315	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SULT1A1—breast cancer	9.58e-06	0.000315	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CD—breast cancer	9.55e-06	0.000314	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDGFA—breast cancer	9.54e-06	0.000313	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFBR2—breast cancer	9.41e-06	0.000309	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APRT—breast cancer	9.39e-06	0.000308	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—IDH1—breast cancer	9.36e-06	0.000307	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA1—breast cancer	9.36e-06	0.000307	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ITPR1—breast cancer	9.26e-06	0.000304	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NAT2—breast cancer	9.25e-06	0.000304	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT5A—breast cancer	9.19e-06	0.000302	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB4—breast cancer	9.19e-06	0.000302	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP3—breast cancer	9.19e-06	0.000302	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CB—breast cancer	9.17e-06	0.000301	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SMAD4—breast cancer	8.9e-06	0.000292	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1R—breast cancer	8.85e-06	0.000291	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ESRRA—breast cancer	8.83e-06	0.00029	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ANGPTL4—breast cancer	8.83e-06	0.00029	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCL8—breast cancer	8.81e-06	0.000289	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HES1—breast cancer	8.69e-06	0.000285	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NCOR1—breast cancer	8.64e-06	0.000284	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PLA2G4A—breast cancer	8.64e-06	0.000284	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CSF2—breast cancer	8.55e-06	0.000281	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF1—breast cancer	8.55e-06	0.000281	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—RAF1—breast cancer	8.53e-06	0.00028	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NRG1—breast cancer	8.49e-06	0.000279	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—H2AFX—breast cancer	8.42e-06	0.000277	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—IL2—breast cancer	8.42e-06	0.000276	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPI—breast cancer	8.37e-06	0.000275	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HADHB—breast cancer	8.37e-06	0.000275	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—E2F1—breast cancer	8.37e-06	0.000275	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CB—breast cancer	8.33e-06	0.000273	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—DPYD—breast cancer	8.11e-06	0.000266	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MED12—breast cancer	8.11e-06	0.000266	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SPP1—breast cancer	8.04e-06	0.000264	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCL8—breast cancer	8e-06	0.000263	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALDOA—breast cancer	7.99e-06	0.000262	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALDH1A1—breast cancer	7.98e-06	0.000262	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALDH7A1—breast cancer	7.98e-06	0.000262	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB3—breast cancer	7.95e-06	0.000261	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGFR2—breast cancer	7.94e-06	0.000261	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA3—breast cancer	7.75e-06	0.000255	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC2A2—breast cancer	7.7e-06	0.000253	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NME1—breast cancer	7.65e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—FHL2—breast cancer	7.65e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UMPS—breast cancer	7.65e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ADSL—breast cancer	7.65e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PHGDH—breast cancer	7.65e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL2—breast cancer	7.65e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TERT—breast cancer	7.62e-06	0.00025	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTR—breast cancer	7.54e-06	0.000248	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CPT1A—breast cancer	7.54e-06	0.000248	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCG2—breast cancer	7.54e-06	0.000248	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—BRIP1—breast cancer	7.51e-06	0.000246	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HPSE—breast cancer	7.51e-06	0.000246	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LDHB—breast cancer	7.51e-06	0.000246	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HPGDS—breast cancer	7.4e-06	0.000243	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGFR1—breast cancer	7.4e-06	0.000243	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HBA1—breast cancer	7.35e-06	0.000241	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HIF1A—breast cancer	7.29e-06	0.000239	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ACHE—breast cancer	7.18e-06	0.000236	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTT1—breast cancer	7.18e-06	0.000236	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMMR—breast cancer	7.12e-06	0.000234	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA3—breast cancer	7.12e-06	0.000234	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCC1—breast cancer	7.12e-06	0.000234	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LEP—breast cancer	7.11e-06	0.000233	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CAV1—breast cancer	7.05e-06	0.000231	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KDR—breast cancer	6.97e-06	0.000229	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARGC1B—breast cancer	6.89e-06	0.000226	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP17A1—breast cancer	6.79e-06	0.000223	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ESR1—breast cancer	6.79e-06	0.000223	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ENO1—breast cancer	6.72e-06	0.000221	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTGS1—breast cancer	6.72e-06	0.000221	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FN1—breast cancer	6.71e-06	0.00022	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NFKBIA—breast cancer	6.63e-06	0.000218	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOTCH1—breast cancer	6.56e-06	0.000215	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA4—breast cancer	6.51e-06	0.000214	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CA9—breast cancer	6.51e-06	0.000214	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA2—breast cancer	6.47e-06	0.000212	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CG—breast cancer	6.42e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KIT—breast cancer	6.42e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APC—breast cancer	6.42e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGF—breast cancer	6.35e-06	0.000208	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA2—breast cancer	6.34e-06	0.000208	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPX2—breast cancer	6.34e-06	0.000208	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—FASN—breast cancer	6.28e-06	0.000206	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPX4—breast cancer	6.26e-06	0.000206	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SULT1A1—breast cancer	6.26e-06	0.000206	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—BCHE—breast cancer	6.25e-06	0.000205	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC5A5—breast cancer	6.17e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAPK3—breast cancer	6.15e-06	0.000202	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA1—breast cancer	6.12e-06	0.000201	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—IDH1—breast cancer	6.12e-06	0.000201	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NAT2—breast cancer	6.05e-06	0.000199	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—BRAF—breast cancer	6.03e-06	0.000198	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC2A1—breast cancer	5.96e-06	0.000196	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NQO1—breast cancer	5.96e-06	0.000196	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1—breast cancer	5.88e-06	0.000193	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT2—breast cancer	5.87e-06	0.000193	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EGFR—breast cancer	5.85e-06	0.000192	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP3A4—breast cancer	5.82e-06	0.000191	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1B1—breast cancer	5.72e-06	0.000188	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CD—breast cancer	5.64e-06	0.000185	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSP90AA1—breast cancer	5.61e-06	0.000184	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	5.59e-06	0.000183	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SERPINE1—breast cancer	5.58e-06	0.000183	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—KRAS—breast cancer	5.52e-06	0.000181	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA1—breast cancer	5.45e-06	0.000179	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—STK11—breast cancer	5.38e-06	0.000176	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP19A1—breast cancer	5.38e-06	0.000176	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOS3—breast cancer	5.33e-06	0.000175	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MED12—breast cancer	5.31e-06	0.000174	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—DPYD—breast cancer	5.31e-06	0.000174	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALDOA—breast cancer	5.22e-06	0.000171	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	5.08e-06	0.000167	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA3—breast cancer	5.07e-06	0.000166	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MDM2—breast cancer	5.06e-06	0.000166	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RAF1—breast cancer	5.04e-06	0.000165	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC2A2—breast cancer	5.03e-06	0.000165	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RELA—breast cancer	5.02e-06	0.000165	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—COMT—breast cancer	5e-06	0.000164	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB2—breast cancer	4.98e-06	0.000164	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTP1—breast cancer	4.97e-06	0.000163	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CPT1A—breast cancer	4.93e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCG2—breast cancer	4.93e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTR—breast cancer	4.93e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MTOR—breast cancer	4.92e-06	0.000161	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CB—breast cancer	4.92e-06	0.000161	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMOX1—breast cancer	4.9e-06	0.000161	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ITPR1—breast cancer	4.89e-06	0.000161	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HPGDS—breast cancer	4.84e-06	0.000159	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HBA1—breast cancer	4.81e-06	0.000158	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL8—breast cancer	4.73e-06	0.000155	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCB1—breast cancer	4.71e-06	0.000155	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HRAS—breast cancer	4.7e-06	0.000154	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ACHE—breast cancer	4.69e-06	0.000154	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTT1—breast cancer	4.69e-06	0.000154	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TYMS—breast cancer	4.62e-06	0.000152	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1B—breast cancer	4.62e-06	0.000152	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.57e-06	0.00015	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—breast cancer	4.57e-06	0.00015	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOR1—breast cancer	4.57e-06	0.00015	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT1—breast cancer	4.57e-06	0.00015	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP3—breast cancer	4.52e-06	0.000149	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL2—breast cancer	4.52e-06	0.000148	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—breast cancer	4.49e-06	0.000148	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP17A1—breast cancer	4.44e-06	0.000146	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCND1—breast cancer	4.4e-06	0.000145	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ENO1—breast cancer	4.4e-06	0.000144	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTGS1—breast cancer	4.4e-06	0.000144	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—JUN—breast cancer	4.39e-06	0.000144	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GPX1—breast cancer	4.38e-06	0.000144	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CTNNB1—breast cancer	4.36e-06	0.000143	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1A1—breast cancer	4.33e-06	0.000142	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2D6—breast cancer	4.31e-06	0.000142	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ERCC2—breast cancer	4.3e-06	0.000141	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP9—breast cancer	4.28e-06	0.00014	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1A—breast cancer	4.26e-06	0.00014	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTEN—breast cancer	4.25e-06	0.00014	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA2—breast cancer	4.23e-06	0.000139	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK8—breast cancer	4.16e-06	0.000136	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT1—breast cancer	4.15e-06	0.000136	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—FASN—breast cancer	4.1e-06	0.000135	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—BCHE—breast cancer	4.09e-06	0.000134	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTHFR—breast cancer	4.04e-06	0.000133	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC5A5—breast cancer	4.04e-06	0.000133	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SRC—breast cancer	3.94e-06	0.000129	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.9e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NQO1—breast cancer	3.9e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—breast cancer	3.84e-06	0.000126	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT3—breast cancer	3.8e-06	0.000125	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1B1—breast cancer	3.74e-06	0.000123	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CAV1—breast cancer	3.73e-06	0.000122	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.67e-06	0.00012	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK3—breast cancer	3.63e-06	0.000119	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA1—breast cancer	3.57e-06	0.000117	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MYC—breast cancer	3.53e-06	0.000116	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFB1—breast cancer	3.52e-06	0.000116	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—STK11—breast cancer	3.51e-06	0.000115	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.51e-06	0.000115	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGFR—breast cancer	3.45e-06	0.000113	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CG—breast cancer	3.39e-06	0.000111	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—COMT—breast cancer	3.27e-06	0.000107	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KRAS—breast cancer	3.26e-06	0.000107	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTP1—breast cancer	3.25e-06	0.000107	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMOX1—breast cancer	3.21e-06	0.000105	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ITPR1—breast cancer	3.2e-06	0.000105	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCB1—breast cancer	3.08e-06	0.000101	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TYMS—breast cancer	3.02e-06	9.92e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CA—breast cancer	3e-06	9.84e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOR1—breast cancer	2.99e-06	9.81e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—breast cancer	2.99e-06	9.81e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.99e-06	9.81e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.98e-06	9.79e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALB—breast cancer	2.95e-06	9.67e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TP53—breast cancer	2.9e-06	9.52e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPX1—breast cancer	2.86e-06	9.39e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.83e-06	9.3e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NOS3—breast cancer	2.82e-06	9.25e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ERCC2—breast cancer	2.81e-06	9.22e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HRAS—breast cancer	2.77e-06	9.11e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—breast cancer	2.66e-06	8.72e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTHFR—breast cancer	2.64e-06	8.67e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.6e-06	8.54e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTGS2—breast cancer	2.58e-06	8.46e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT1—breast cancer	2.45e-06	8.04e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CAV1—breast cancer	2.44e-06	8e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTEN—breast cancer	2.25e-06	7.38e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.22e-06	7.28e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.95e-06	6.4e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALB—breast cancer	1.93e-06	6.32e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NOS3—breast cancer	1.84e-06	6.05e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.7e-06	5.58e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTGS2—breast cancer	1.68e-06	5.53e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.59e-06	5.2e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTEN—breast cancer	1.47e-06	4.82e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKT1—breast cancer	1.29e-06	4.25e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.04e-06	3.4e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKT1—breast cancer	8.47e-07	2.78e-05	CbGpPWpGaD
